Literature DB >> 29079103

Induction of lung CD8+ T cell responses by consecutive inoculations of a poly(I:C) influenza vaccine.

Miyu Moriyama1, Haruko Takeyama2, Hideki Hasegawa3, Takeshi Ichinohe4.   

Abstract

The cytotoxic T lymphocyte (CTL) response plays a key role in host recovery from influenza virus infection and in subsequent immunity. Compared to natural infection with influenza virus, however, intranasal vaccination with adjuvant-combined inactivated vaccine elicits only moderate CTL responses. Here we demonstrate that 5 days of consecutive, intranasal vaccination with a combination of inactivated influenza vaccine and poly(I:C) elicits a strong CTL response in the lung. Antigen-captured respiratory DCs did efficiently migrate from the lung to the mediastinal lymph node (mLN) after the 5 day series of inoculations with vaccine and poly(I:C). Importantly, formalin-inactivated whole virus vaccine and poly(I:C) adjuvant have synergic effects on consecutive vaccinations to elicit a strong CTL response in the lung. Although the CTL response was less effective against heterologous influenza virus, we show for the first time that intranasal administration of inactivated influenza virus vaccine and poly(I:C) for 5 consecutive days can elicit high levels of influenza virus-specific CD8+ T cells in the lung.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adjuvant; CTL; Influenza virus; Intranasal vaccine; Poly(I:C)

Mesh:

Substances:

Year:  2017        PMID: 29079103     DOI: 10.1016/j.vaccine.2017.10.038

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

Review 1.  São Paulo School of Advanced Sciences on Vaccines: an overview.

Authors:  Sara Sorgi; Vivian Bonezi; Mariana R Dominguez; Alba Marina Gimenez; Irina Dobrescu; Silvia Boscardin; Helder I Nakaya; Daniel Y Bargieri; Irene S Soares; Eduardo L V Silveira
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2020-04-06

2.  AddaVax Formulated with PolyI:C as a Potential Adjuvant of MDCK-based Influenza Vaccine Enhances Local, Cellular, and Antibody Protective Immune Response in Mice.

Authors:  Xuanxuan Nian; Jiayou Zhang; Tao Deng; Jing Liu; Zheng Gong; Chuanshuo Lv; Luyao Yao; Junying Li; Shihe Huang; Xiaoming Yang
Journal:  AAPS PharmSciTech       Date:  2021-11-11       Impact factor: 3.246

3.  Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein.

Authors:  Julia T Castro; Patrick Azevedo; Marcílio J Fumagalli; Natalia S Hojo-Souza; Natalia Salazar; Gregório G Almeida; Livia I Oliveira; Lídia Faustino; Lis R Antonelli; Tomas G Marçal; Marconi Augusto; Bruno Valiate; Alex Fiorini; Bruna Rattis; Simone G Ramos; Mariela Piccin; Osvaldo Campos Nonato; Luciana Benevides; Rubens Magalhães; Bruno Cassaro; Gabriela Burle; Daniel Doro; Jorge Kalil; Edson Durigon; Andrés Salazar; Otávia Caballero; Helton Santiago; Alexandre Machado; João S Silva; Flávio da Fonseca; Ana Paula Fernandes; Santuza R Teixeira; Ricardo T Gazzinelli
Journal:  Nat Commun       Date:  2022-08-17       Impact factor: 17.694

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.